Simkin Named Finalist For Washington Business Journal's "Top Washington Lawyer"
August 3, 2007
Washington Business Journal’s
Foley & Lardner LLP announced today that Michelle M. Simkin, a partner in Foley’s Washington, D.C. office and chair of the Biotechnology & Pharmaceutical Practice, was named a finalist for Washington Business Journal’s 2007 Top Washington Lawyer. Simkin is also a member of the Life Sciences and Nanotechnology Industry Teams.
Simkin was one of 54 finalists who were selected by a panel of judges from a pool of 500 nominated candidates. The list of finalists appeared in the August 3, 2007 issue of the newspaper. The Washington Business Journal will honor the finalists and announce the winners at a reception on September 11, 2007 at the Four Seasons, Washington, D.C.
People
Related News
May 1, 2026
In the News
David Rosen Weighs in on SCOTUS Review of Skinny Label Patent Dispute
Foley & Lardner LLP partner David Rosen is featured across the media for his perspective on the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.
April 27, 2026
In the News
Jesse Neil Featured as a Distinguished Leader in Law.com's Southeastern Legal Awards
Foley & Lardner LLP partner Jesse Neil is recognized in Law.com as one of the Distinguished Leader honorees for the 2026 Southeastern Legal Awards.
April 27, 2026
In the News
David Rosen and William Holtz Analyze FDA Approval Speed, Biotech Pressures
Foley & Lardner LLP attorneys David Rosen and William Holtz are quoted in the PharmaVoice article, “FDA’s need for speed could strain small biotechs. Here’s how they can keep up,” examining the FDA’s accelerated drug approval initiatives and its impact on smaller pharmaceutical companies.